Next Article in Journal
Characterization of the Transcriptome and Gene Expression of Tetraploid Black Locust Cuttings in Response to Etiolation
Next Article in Special Issue
Circular RNAs (circRNAs) in Health and Disease
Previous Article in Journal
Epigenetic Basis of Cellular Senescence and Its Implications in Aging
Previous Article in Special Issue
Alternative Splicing in Breast Cancer and the Potential Development of Therapeutic Tools
Article Menu

Export Article

Open AccessReview
Genes 2017, 8(12), 344; doi:10.3390/genes8120344

Alternative Splicing of L-type CaV1.2 Calcium Channels: Implications in Cardiovascular Diseases

1
Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117593, Singapore
2
Neurobiology/Ageing Programme, Center for Life Sciences, NUS Graduate School for Integrative Sciences and Engineering, Singapore 117456, Singapore
3
Neurobiology/Ageing Programme, Center for Life Sciences, National University of Singapore, Singapore 117456, Singapore
*
Author to whom correspondence should be addressed.
Received: 11 October 2017 / Revised: 9 November 2017 / Accepted: 21 November 2017 / Published: 24 November 2017
(This article belongs to the Special Issue Aberrant Pre-mRNA Splicing in Disease)
View Full-Text   |   Download PDF [2019 KB, uploaded 29 November 2017]   |  

Abstract

L-type CaV1.2 calcium channels are the major pathway for Ca2+ influx to initiate the contraction of smooth and cardiac muscles. Alteration of CaV1.2 channel function has been implicated in multiple cardiovascular diseases, such as hypertension and cardiac hypertrophy. Alternative splicing is a post-transcriptional mechanism that expands CaV1.2 channel structures to modify function, pharmacological and biophysical property such as calcium/voltage-dependent inactivation (C/VDI), or to influence its post-translational modulation by interacting proteins such as Galectin-1. Alternative splicing has generated functionally diverse CaV1.2 isoforms that can be developmentally regulated in the heart, or under pathophysiological conditions such as in heart failure. More importantly, alternative splicing of certain exons of CaV1.2 has been reported to be regulated by splicing factors such as RNA-binding Fox-1 homolog 1/2 (Rbfox 1/2), polypyrimidine tract-binding protein (PTBP1) and RNA-binding motif protein 20 (RBM20). Understanding how CaV1.2 channel function is remodelled in disease will provide better information to guide the development of more targeted approaches to discover therapeutic agents for cardiovascular diseases. View Full-Text
Keywords: L-type CaV1.2 calcium channel; alternative splicing; cardiovascular diseases L-type CaV1.2 calcium channel; alternative splicing; cardiovascular diseases
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Hu, Z.; Liang, M.C.; Soong, T.W. Alternative Splicing of L-type CaV1.2 Calcium Channels: Implications in Cardiovascular Diseases. Genes 2017, 8, 344.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Genes EISSN 2073-4425 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top